PAK2 (p21 activated kinase 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
CLLU1 (Chronic lymphocytic leukemia up-regulated 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
MOXD2P (monooxygenase, DBH-like 2, pseudogene ) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
TDH (L-threonin dehydrogenase) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
FOXP2 (forkhead box P2) |
Naruya Saitou |
Genetics |
Absolute Difference |
SIGLEC5 (sialic acid binding Ig-like lectin 5 ) |
Ajit Varki |
Genetics |
Likely Difference |
SIGLEC6 (sialic acid binding Ig-like lectin 6) |
Ajit Varki |
Genetics |
Absolute Difference |
AMY1A (amylase, alpha 1A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
SLC2A1 (Solute carrier family 2 (facilitated glucose transporter) member 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
DDX11L (DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 like) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
MRC1 (Mannose receptor, C type 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
FZD8 (frizzled 8) |
Majesta O'Bleness |
Genetics |
Likely Difference |
THBS4 (Thrombospondin 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
SIGLEC9 (sialic acid binding Ig-like lectin 9) |
Ajit Varki |
Genetics |
Likely Difference |
UOX (urate oxidase, pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
No Difference |
SLC2A4 (Solute carrier family 2 (facilitated glucose transporter) member 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
DNAH10OS (Dynein, axonemal heavy chain 10 opposite strand) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
NAIP (NLR family, apoptosis inhibitory protein ) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
DCHS1 (Dachsous Cadherin-Related 1) |
Majesta O'Bleness |
Genetics |
Likely Difference |
ZNF322 (Zinc finger protein 322) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
KRT41P (keratin 41 pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
TAS2R38 (taste receptor, type 2, member 38) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
APOC1 (apolipoprotein C-I) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
DRD5 (Dopamine receptor D5) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
NCF1 (Neutrophil cytosolic factor 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
DUX4 (double homeobox 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
FGFR2 (fibroblast growth factor receptor 2) |
Matthew Boisvert, Majesta O'Bleness, James Sikela |
Genetics |
No Difference |
TTR (transthyretin) |
MOCA Author |
Genetics |
Likely Difference |
AQP7 (aquaporin 7) |
Laura Dumas, James Sikela |
Genetics |
Likely Difference |
DUSP22 (Dual specificity phosphatase 22) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
OCLN (Occludin) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
KIR3DL1 (killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
MCPH1 (microcephalin 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
TH (tyrosine hydroxylase) |
Landon Klein |
Genetics |
Relative Difference |
EDAR (ectodysplasin A receptor) |
Majesta O'Bleness |
Genetics |
Likely Difference |
E2F6 (E2F transcription factor 6) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
PDE4DIP (Phosphodiesterase 4D interacting protein) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
CASC5 (Cancer Susceptibility Candidate 5 ) |
Majesta O'Bleness |
Genetics |
Likely Difference |
MC1R (melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) ) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
FCGR1A (Fc fragment of IgG, high affinity Ia, receptor (CD64)) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
PTPN20A (Protein tyrosine phosphatase, non-receptor type 20A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
SPANXB (SPANX family, member B) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
NBPF15 (neuroblastoma breakpoint family, member 15) |
Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
FRMPD2 (FERM and PDZ domain containing 2) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
SERPINA13 (Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
SPANXC (SPANX family, member C) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
APOE (apolipoprotein E) |
Caleb Finch |
Genetics |
Relative Difference |
MHC Class I |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
SIGLEC14 (sialic acid binding Ig-like lectin 14) |
Ajit Varki |
Genetics |
Absolute Difference |
GLRA4 (Glycine receptor, alpha 4) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
RAB3IP (RAB3A interacting protein) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
AHI1 (Abelson Helper Integration Site 1 ) |
Majesta O'Bleness |
Genetics |
Likely Difference |
ASPM (asp (abnormal spindle) homolog, microcephaly associated) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
MYH16 (myosin, heavy chain 16 pseudogene) |
Naruya Saitou |
Genetics |
Absolute Difference |
SIGLEC7 (sialic acid binding Ig-like lectin 7 ) |
Ajit Varki |
Genetics |
Likely Difference |
ABCB10 (ATP-binding cassette, subfamily B (MDR/TAP) member 10) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
GRIN3A (Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
RGS6 (Regulator of G-protein signaling 6) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
OR4F17 (olfactory receptor, family 4, subfamily F, member 17) |
Majesta O'Bleness, James Sikela |
Genetics |
|
CASP12 (caspase-12 gene/pseudogene) |
Majesta O'Bleness, James Sikela |
Genetics |
Relative Difference |
PCDH11XY (protocadherin 11 X Y linked) |
Tim Crow, Majesta O'Bleness, James Sikela |
Genetics |
Absolute Difference |
SIGLEC16 (sialic acid binding Ig-like lectin 16) |
Ajit Varki |
Genetics |
Likely Difference |
ARHGEF5 (Rho guanine nucleotide exchange factor (GEF) 5) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
GRIN3B (Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
SERF1A (Small EDRK-rich factor 1A) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
TRGV10 (T cell receptor gamma variable 10) |
Majesta O'Bleness, James Sikela |
Genetics |
|
CCL3L1 (chemokine (C-C motif) ligand 3-like 1) |
Majesta O'Bleness, James Sikela |
Genetics |
Likely Difference |
PDYN (prodynorphin) |
Majesta O'Bleness, James Sikela |
Genetics |
Speculative Difference |
DHEA/DHEAS Circulating Levels |
MOCA Author |
Endocrinology |
Relative Difference |
Androgen Metabolism in the Brain |
Camille Toarmino |
Endocrinology |
|
Thyroid Hormone Metabolism |
MOCA Author |
Endocrinology |
Likely Difference |
Arsenic Detoxification |
MOCA Author |
Pharmacology |
Likely Difference |
Mind-Altering Drug Use |
Landon Klein |
Pharmacology |
Likely Difference |
Self-Medication (Zoopharmacognosy) |
Majesta O'Bleness |
Pharmacology |
Relative Difference |
Sarcoidosis |
Nissi Varki |
Pathology |
Speculative Difference |
Systemic Lupus Erythematosus |
Nissi Varki |
Pathology |
Speculative Difference |
Serum Lp(a) Level |
MOCA Author |
Pathology |
Relative Difference |
Serum Cholesterol Level |
Caleb Finch |
Pathology |
Likely Difference |
Alzheimer's Disease Pathology (Neurofibrillary Tangles) |
Caleb Finch |
Pathology |
Absolute Difference |
Serum Alkaline Phosphatase Level |
MOCA Author |
Pathology |
Relative Difference |
Uterine Adenomyosis and Endometriosis |
Nissi Varki |
Pathology |
Relative Difference |
Neoplasm Types and Prevalence |
Nissi Varki |
Pathology |
Relative Difference |
Serum Uric Acid Level |
MOCA Author |
Pathology |
Relative Difference |
Atherosclerosis |
Nissi Varki |
Pathology |
Relative Difference |
Blood Group Antigen Types and Prevalence |
Leela Davies |
Pathology |
Relative Difference |
Rheumatoid Arthritis |
MOCA Author |
Pathology |
Relative Difference |
Erythrocyte Sedimentation Rate |
MOCA Author |
Pathology |
Relative Difference |
Age-Associated Osteoporosis |
MOCA Author |
Pathology |
Speculative Difference |
Major Basic Protein in Placenta and Eosinophils |
MOCA Author |
Pathology |
Likely Difference |
Gout |
Nissi Varki |
Pathology |
Speculative Difference |
Absolute Leukocyte Count |
MOCA Author |
Pathology |
Absolute Difference |
Hemochromatosis |
Nissi Varki |
Pathology |
Speculative Difference |
Absolute Lymphocyte Count |
Robert Thomas |
Pathology |
Absolute Difference |
Inflammatory Bowel Disease |
Nissi Varki |
Pathology |
Speculative Difference |
Absolute Neutrophil Count |
MOCA Author |
Pathology |
Absolute Difference |
Colonic Polyps |
Nissi Varki |
Pathology |
Relative Difference |
Diverticulosis |
Nissi Varki |
Pathology |
Absolute Difference |
Benign Prostatic Hyperplasia |
Nissi Varki |
Pathology |
Likely Difference |
Polycystic Ovarian Disease |
Nissi Varki |
Pathology |
Absolute Difference |
Incisor Morphology |
MOCA Author |
Dental Biology and Disease |
|